Allen Operations’s Ginkgo Bioworks DNA Stock Holding History

Allen Operations’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$795K	Hold	61,951	–	–	0.08%	31
2026 Q2	$614K	Hold	61,951	–	–	0.09%	30
2026 Q1	$380K	Hold	61,951	–	–	0.06%	35
2025 Q4	$515K	Hold	61,951	–	–	0.06%	35
2025 Q3	$903K	Hold	61,951	–	–	0.11%	34
2025 Q2	$697K	Hold	61,951	–	–	0.1%	31
2025 Q1	$353K	Hold	61,951	–	–	0.06%	29
2024 Q4	$608K	Sell	61,951 -3	-0%	-$26	0.1%	29
2024 Q3	$505K	Buy	61,954 +2	+0%	+$20	0.09%	30
2024 Q2	$828K	Hold	61,952	–	–	0.16%	26
2024 Q1	$2.87M	Hold	61,952	–	–	0.55%	22
2023 Q4	$4.19M	Hold	61,952	–	–	0.83%	21
2023 Q3	$4.49M	Hold	61,952	–	–	0.99%	22
2023 Q2	$4.61M	Hold	61,952	–	–	1.02%	21
2023 Q1	$3.3M	Hold	61,952	–	–	0.84%	22
2022 Q4	$4.19M	Buy	61,952 +5,727	+10%	+$527K	1.12%	19
2022 Q3	$7.02M	Hold	56,225	–	–	1.87%	16
2022 Q2	$5.35M	Hold	56,225	–	–	1.35%	18
2022 Q1	$9.06M	Hold	56,225	–	–	1.6%	19
2021 Q4	$18.7M	Buy	56,225 +1,638	+3%	+$778K	2.6%	16
2021 Q3	$25.3M	Buy	+54,587	New	+$26.6M	3.92%	10

Other funds holding DNA

J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return

Q Fund Management (Hong Kong) Hong Kong $104M AUM 789.73% 1-Year Est. Return

Modera Wealth Management Westwood, New Jersey $9.5B AUM 16% 1-Year Est. Return

Boston Standard Wealth Management Winchester, Massachusetts $696M AUM 8.98% 1-Year Est. Return

TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Arizona State Retirement System Phoenix, Arizona $20.3B AUM 36.55% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Allen Operations's DNA Position: Q3 2026 in Review

Allen Operations held its Ginkgo Bioworks (DNA) position steady in Q3 2026 at 61,951 shares worth $795K. The position accounts for 0.08% of the portfolio, ranked #31.

Allen Operations first reported a position in DNA in Q3 2021 and has held it in 21 quarters since. The position peaked at $25.3M in Q3 2021. 39 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

Allen Operations held 61,951 shares of Ginkgo Bioworks worth $795K as of Q3 2026.
Allen Operations left its Ginkgo Bioworks share count unchanged in Q3 2026.
Ginkgo Bioworks made up 0.08% of Allen Operations's portfolio in Q3 2026, its #31 holding.
Allen Operations first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 21 quarters since.
Allen Operations's Ginkgo Bioworks position peaked at $25.3M in Q3 2021.
39 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Allen Operations's 13F filing for Q3 2026, filed 3 Nov 2026.